(-)-epigallocatechin 3-gallate multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIP13 mRNA CTD PMID:22079256 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of TRIP13 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of TRIP13 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression ISO Trip13 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of TRIP13 mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of TRIP13 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIP13 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO TRIP13 (Homo sapiens) 6480464 Estradiol results in increased expression of TRIP13 mRNA CTD PMID:16474171 and PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIP13 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO TRIP13 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of TRIP13 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TRIP13 mRNA CTD PMID:19465110 and PMID:19770486 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO TRIP13 (Homo sapiens) 6480464 2 more ... CTD PMID:17547211 2-palmitoylglycerol increases expression ISO TRIP13 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of TRIP13 mRNA CTD PMID:37199045 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Trip13 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of TRIP13 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO TRIP13 (Homo sapiens) 6480464 bisphenol S results in increased expression of TRIP13 mRNA CTD PMID:27685785 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of TRIP13 mRNA CTD PMID:19191707 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of TRIP13 mRNA CTD PMID:19191707 6-propyl-2-thiouracil increases expression ISO Trip13 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of TRIP13 mRNA CTD PMID:24780913 acetamide increases expression ISO Trip13 (Rattus norvegicus) 6480464 acetamide results in increased expression of TRIP13 mRNA CTD PMID:31881176 acetohydrazide decreases expression EXP 6480464 acetylhydrazine results in decreased expression of TRIP13 mRNA CTD PMID:15282401 acrolein multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of TRIP13 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of TRIP13 mRNA CTD PMID:32699268 acrylamide decreases expression ISO TRIP13 (Homo sapiens) 6480464 Acrylamide results in decreased expression of TRIP13 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO TRIP13 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of TRIP13 protein CTD PMID:20106945 aflatoxin B1 multiple interactions ISO Trip13 (Rattus norvegicus) 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of TRIP13 mRNA CTD PMID:25450479 aflatoxin B1 increases expression ISO Trip13 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of TRIP13 mRNA CTD PMID:23630614 all-trans-retinoic acid decreases expression ISO TRIP13 (Homo sapiens) 6480464 Tretinoin results in decreased expression of TRIP13 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of TRIP13 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of TRIP13 mRNA CTD PMID:32699268 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of TRIP13 mRNA CTD PMID:18929588 arsenous acid increases expression ISO TRIP13 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of TRIP13 mRNA CTD PMID:17547211 atrazine decreases expression ISO TRIP13 (Homo sapiens) 6480464 Atrazine results in decreased expression of TRIP13 mRNA CTD PMID:22378314 azathioprine decreases expression ISO TRIP13 (Homo sapiens) 6480464 Azathioprine results in decreased expression of TRIP13 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of TRIP13 mRNA CTD PMID:20713471 benzo[a]pyrene increases expression ISO TRIP13 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of TRIP13 mRNA CTD PMID:32234424 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of TRIP13 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO TRIP13 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of TRIP13 mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide decreases expression ISO TRIP13 (Homo sapiens) 6480464 Mustard Gas results in decreased expression of TRIP13 mRNA CTD PMID:25102026 bisphenol A increases expression ISO TRIP13 (Homo sapiens) 6480464 bisphenol A results in increased expression of TRIP13 mRNA CTD PMID:16474171 bisphenol A increases expression ISO Trip13 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of TRIP13 mRNA CTD PMID:30816183 and PMID:32528016 bisphenol A decreases expression ISO TRIP13 (Homo sapiens) 6480464 bisphenol A results in decreased expression of TRIP13 mRNA CTD PMID:29275510 bisphenol A decreases expression ISO Trip13 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of TRIP13 mRNA CTD PMID:25181051 calcitriol multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TRIP13 mRNA CTD PMID:21592394 calcitriol decreases expression ISO TRIP13 (Homo sapiens) 6480464 Calcitriol results in decreased expression of TRIP13 mRNA CTD PMID:21592394 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon results in decreased expression of TRIP13 mRNA CTD PMID:25620056 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of TRIP13 mRNA CTD PMID:37019170 cisplatin affects response to substance ISO TRIP13 (Homo sapiens) 6480464 TRIP13 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cobalt dichloride decreases expression ISO TRIP13 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of TRIP13 mRNA CTD PMID:19320972 and PMID:19376846 copper atom increases expression EXP 6480464 Copper results in increased expression of TRIP13 mRNA CTD PMID:17205981 copper(0) increases expression EXP 6480464 Copper results in increased expression of TRIP13 mRNA CTD PMID:17205981 coumestrol multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO TRIP13 (Homo sapiens) 6480464 Coumestrol results in increased expression of TRIP13 mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO TRIP13 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of TRIP13 mRNA CTD PMID:19159671 and PMID:25562108 diarsenic trioxide increases expression ISO TRIP13 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of TRIP13 mRNA CTD PMID:17547211 diazinon increases methylation ISO TRIP13 (Homo sapiens) 6480464 Diazinon results in increased methylation of TRIP13 gene CTD PMID:22964155 dibenzo[a,l]pyrene decreases expression EXP 6480464 dibenzo(a and l)pyrene results in decreased expression of TRIP13 mRNA CTD PMID:25908611 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of TRIP13 mRNA CTD PMID:21266533 dieldrin increases expression ISO Trip13 (Rattus norvegicus) 6480464 Dieldrin results in increased expression of TRIP13 mRNA CTD PMID:23153324 diethyl maleate increases expression ISO Trip13 (Rattus norvegicus) 6480464 diethyl maleate results in increased expression of TRIP13 mRNA CTD PMID:21161181 dioxygen decreases expression ISO TRIP13 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of TRIP13 mRNA CTD PMID:26516004 Enterolactone multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIP13 mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TRIP13 protein CTD PMID:23301498 ethyl methanesulfonate decreases expression ISO TRIP13 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of TRIP13 mRNA CTD PMID:23649840 folic acid multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TRIP13 mRNA CTD PMID:24657277 formaldehyde decreases expression ISO TRIP13 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of TRIP13 mRNA CTD PMID:23649840 genistein increases expression ISO TRIP13 (Homo sapiens) 6480464 Genistein results in increased expression of TRIP13 mRNA CTD PMID:16474171 heptachlor increases expression ISO Trip13 (Rattus norvegicus) 6480464 Heptachlor results in increased expression of TRIP13 mRNA CTD PMID:23153324 ivermectin decreases expression ISO TRIP13 (Homo sapiens) 6480464 Ivermectin results in decreased expression of TRIP13 protein CTD PMID:32959892 Lasiocarpine increases expression ISO TRIP13 (Homo sapiens) 6480464 lasiocarpine results in increased expression of TRIP13 mRNA CTD PMID:32234424 leflunomide decreases expression ISO TRIP13 (Homo sapiens) 6480464 leflunomide results in decreased expression of TRIP13 mRNA CTD PMID:28988120 lidocaine increases expression ISO Trip13 (Rattus norvegicus) 6480464 Lidocaine results in increased expression of TRIP13 mRNA CTD PMID:35283115 linezolid decreases expression ISO Trip13 (Rattus norvegicus) 6480464 Linezolid results in decreased expression of TRIP13 mRNA CTD PMID:21296123 mercury atom increases expression ISO TRIP13 (Homo sapiens) 6480464 Mercury results in increased expression of TRIP13 mRNA CTD PMID:17547211 mercury(0) increases expression ISO TRIP13 (Homo sapiens) 6480464 Mercury results in increased expression of TRIP13 mRNA CTD PMID:17547211 methotrexate multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TRIP13 mRNA CTD PMID:24657277 methyl methanesulfonate decreases expression ISO TRIP13 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of TRIP13 mRNA CTD PMID:23649840 mirex increases expression ISO Trip13 (Rattus norvegicus) 6480464 Mirex results in increased expression of TRIP13 mRNA CTD PMID:23153324 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of TRIP13 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions EXP 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TRIP13 mRNA] CTD PMID:17854601 N-Nitrosopyrrolidine decreases expression ISO TRIP13 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of TRIP13 mRNA CTD PMID:32234424 nickel atom increases expression ISO TRIP13 (Homo sapiens) 6480464 Nickel results in increased expression of TRIP13 mRNA CTD PMID:25583101 niclosamide decreases expression ISO TRIP13 (Homo sapiens) 6480464 Niclosamide results in decreased expression of TRIP13 mRNA CTD PMID:28284560 oxaliplatin multiple interactions ISO Trip13 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TRIP13 mRNA CTD PMID:25729387 ozone increases expression EXP 6480464 Ozone results in increased expression of TRIP13 mRNA CTD PMID:25658374 ozone multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of TRIP13 mRNA more ... CTD PMID:32699268 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TRIP13 mRNA more ... CTD PMID:24381131 more ... paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of TRIP13 mRNA CTD PMID:17562736 paracetamol increases expression ISO TRIP13 (Homo sapiens) 6480464 Acetaminophen results in increased expression of TRIP13 mRNA CTD PMID:22230336 PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 perfluorooctanoic acid decreases expression ISO TRIP13 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of TRIP13 mRNA CTD PMID:36326898 phenethyl isothiocyanate decreases expression ISO TRIP13 (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased expression of TRIP13 mRNA CTD PMID:26678675 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of TRIP13 mRNA CTD PMID:23091169 picoxystrobin increases expression ISO TRIP13 (Homo sapiens) 6480464 picoxystrobin results in increased expression of TRIP13 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TRIP13 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of TRIP13 mRNA CTD PMID:18445702 and PMID:23811191 potassium chromate multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIP13 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO TRIP13 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of TRIP13 mRNA CTD PMID:22079256 quercetin affects expression ISO TRIP13 (Homo sapiens) 6480464 Quercetin affects the expression of TRIP13 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of TRIP13 mRNA CTD PMID:19167446 resveratrol increases expression ISO TRIP13 (Homo sapiens) 6480464 resveratrol results in increased expression of TRIP13 mRNA CTD PMID:19167446 rotenone increases expression ISO TRIP13 (Homo sapiens) 6480464 Rotenone results in increased expression of TRIP13 mRNA CTD PMID:33512557 silicon dioxide decreases expression ISO TRIP13 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of TRIP13 mRNA CTD PMID:23806026 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of TRIP13 mRNA CTD PMID:29341224 sodium arsenite affects expression ISO TRIP13 (Homo sapiens) 6480464 sodium arsenite affects the expression of TRIP13 mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO TRIP13 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of TRIP13 protein CTD PMID:30528433 sodium arsenite increases expression ISO TRIP13 (Homo sapiens) 6480464 sodium arsenite results in increased expression of TRIP13 mRNA CTD PMID:34032870 sodium dichromate increases expression ISO Trip13 (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of TRIP13 mRNA CTD PMID:25993096 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of TRIP13 protein CTD PMID:28918527 sulforaphane multiple interactions ISO Trip13 (Rattus norvegicus) 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of TRIP13 mRNA CTD PMID:25450479 sunitinib decreases expression ISO TRIP13 (Homo sapiens) 6480464 Sunitinib results in decreased expression of TRIP13 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of TRIP13 mRNA CTD PMID:29362864 testosterone multiple interactions ISO TRIP13 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TRIP13 mRNA CTD PMID:21592394 testosterone decreases expression ISO TRIP13 (Homo sapiens) 6480464 Testosterone results in decreased expression of TRIP13 mRNA CTD PMID:21592394 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of TRIP13 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of TRIP13 mRNA CTD PMID:31919559 thioacetamide increases expression ISO Trip13 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of TRIP13 mRNA CTD PMID:23411599 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of TRIP13 mRNA CTD PMID:23557971 topotecan multiple interactions ISO Trip13 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TRIP13 mRNA CTD PMID:25729387 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of TRIP13 mRNA CTD PMID:19042947 troglitazone decreases expression ISO TRIP13 (Homo sapiens) 6480464 troglitazone results in decreased expression of TRIP13 mRNA CTD PMID:19140230 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of TRIP13 mRNA CTD PMID:35537566 tunicamycin decreases expression ISO TRIP13 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of TRIP13 mRNA CTD PMID:29453283 urethane decreases expression ISO TRIP13 (Homo sapiens) 6480464 Urethane results in decreased expression of TRIP13 mRNA CTD PMID:28818685 valproic acid decreases expression ISO TRIP13 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of TRIP13 mRNA CTD PMID:19101580 valproic acid affects expression ISO TRIP13 (Homo sapiens) 6480464 Valproic Acid affects the expression of TRIP13 mRNA CTD PMID:25979313 zinc atom increases expression ISO TRIP13 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of TRIP13 mRNA CTD PMID:22171008 zinc(0) increases expression ISO TRIP13 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of TRIP13 mRNA CTD PMID:22171008 zoledronic acid decreases expression ISO TRIP13 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of TRIP13 mRNA CTD PMID:24714768